Phlox Therapeutics
PrivateLast Round
Seed
Nov 6, 2024
Total Funding Raised
$2.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Phlox Therapeutics is a biotechnology company that develops first-in-class RNA therapies for rare genetic cardiomyopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phlox Therapeutics Comparables
Compare Phlox Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nuevocor | 81% | |
| Bayer AG | 73% | |
| BioMarin Pharmaceutical Inc. | 73% |
Phlox Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Nov 6, 2024 | ||||
| Seed | May 9, 2023 | ||||
| Pre Seed | May 16, 2022 |
Phlox Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ROM Utrecht Region | Seed |
| Amsterdam UMC Ventures Holding | Seed |
| Innovation Fund Noord-Holland | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 38% MoM.
- May 14, 2026
Monthly visitors grew 71% MoM, reaching 1.2K.
Phlox Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Phlox Therapeutics's valuation, stock price, and market status.
Is Phlox Therapeutics a public or private company?
Phlox Therapeutics is a private company.
What is the current stock price of Phlox Therapeutics?
Phlox Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Phlox Therapeutics worth (valuation)?
Valuation information for Phlox Therapeutics is not publicly available.
Can I buy Phlox Therapeutics stock?
Phlox Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Phlox Therapeutics's last funding round?
Phlox Therapeutics's most recent funding round was Seed on November 6, 2024.
Who are the main investors in Phlox Therapeutics?
Key investors in Phlox Therapeutics include ROM Utrecht Region, Amsterdam UMC Ventures Holding, Innovation Fund Noord-Holland.
Will Phlox Therapeutics IPO soon?
No public IPO plans have been announced for Phlox Therapeutics.
How can I track Phlox Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Phlox Therapeutics's secondary market activity and sign up for updates.